Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Fortive
FTV
$18.7B
| $45.3M | 0.01% |
819,713
-198,241
| -19% | -$10.3M |
|
827
CALL
Eli Lilly
LLY
$1.09T
| $45.2M | 0.01% |
42,100
-65,100
| -61% | -$62.2M |
|
828
Ingersoll Rand
IR
$33.9B
| $45.2M | 0.01% |
570,451
-126,197
| -18% | -$9.96M |
|
829
Mid-America Apartment Communities
MAA
$15.4B
| $45.2M | 0.01% |
325,058
-6,574
| -2% | -$876K |
|
|
CTRA
830
DELISTED
Coterra Energy
CTRA
| $45.1M | 0.01% |
1,714,083
-364,261
| -18% | -$9.18M |
|
831
Reliance Steel & Aluminium
RS
$22B
| $45M | 0.01% |
155,861
+19,434
| +14% | +$5.46M |
|
832
Plains All American Pipeline
PAA
$16.4B
| $44.9M | 0.01% |
2,502,350
+301,065
| +14% | +$5.12M |
|
833
Packaging Corp of America
PKG
$22.9B
| $44.8M | 0.01% |
217,201
-174,103
| -44% | -$35.4M |
|
834
Cinemark Holdings
CNK
$4.35B
| $44.8M | 0.01% |
1,927,362
+671,510
| +53% | +$17.7M |
|
835
Stride
LRN
$3.32B
| $44.7M | 0.01% |
688,214
+494,215
| +255% | +$44.9M |
|
836
CMS Energy
CMS
$21.7B
| $44.7M | 0.01% |
638,907
-1,555,573
| -71% | -$113M |
|
837
Transocean
RIG
$6.36B
| $44.6M | 0.01% |
10,802,664
+7,535,041
| +231% | +$29.3M |
|
838
CALL
Riot Platforms
RIOT
$8.36B
| $44.6M | 0.01% |
3,520,300
-138,200
| -4% | -$2.36M |
|
839
United Therapeutics
UTHR
$22.7B
| $44.3M | 0.01% |
90,925
-21,921
| -19% | -$10.2M |
|
|
GAP
840
The Gap Inc
GAP
$7.53B
| $44.3M | 0.01% |
1,729,520
-736,423
| -30% | -$17.8M |
|
841
Factset
FDS
$9.89B
| $44.2M | 0.01% |
152,253
-120,282
| -44% | -$33.8M |
|
842
Essex Property Trust
ESS
$18.2B
| $43.9M | 0.01% |
167,934
+13,300
| +9% | +$3.44M |
|
843
Constellation Brands
STZ
$22.7B
| $43.9M | 0.01% |
318,350
-95,567
| -23% | -$13.1M |
|
844
PUT
Booking.com
BKNG
$158B
| $43.9M | 0.01% |
205,000
+80,000
| +64% | +$16.5M |
|
845
CALL
iShares Semiconductor ETF
SOXX
$45.3B
| $43.7M | 0.01% |
+145,000
| New | +$42.8M |
|
846
Teva Pharmaceuticals
TEVA
$42.4B
| $43.6M | 0.01% |
1,395,671
+720,545
| +107% | +$17.8M |
|
847
PPG Industries
PPG
$25.8B
| $43.5M | 0.01% |
424,351
-195,654
| -32% | -$19.7M |
|
848
Avery Dennison
AVY
$13.6B
| $43.4M | 0.01% |
238,539
+11,956
| +5% | +$2.07M |
|
849
United Microelectronic
UMC
$48.1B
| $43.3M | 0.01% |
5,511,784
+1,435,780
| +35% | +$10.9M |
|
|
ECHO
850
PUT
EchoStar
ECHO
$25.8B
| $43.3M | 0.01% |
398,200
+95,000
| +31% | +$7.74M |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.